GSK boosts cancer portfolio with $10.6 billion Nuvalent takeover
Deal values cancer drug developer Nuvalent at $124 per shareThat is a 40% premium to the US-listed firm’s…
AstraZeneca plans to invest $405 million in Britain, PM Starmer says
LONDON, April 29 (Reuters) – Prime Minister Keir Starmer said on Wednesday that Britain’s biggest company AstraZeneca (AZN.L),…